Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Windward Launches Organization Defined Risk, Setting a New Standard of Risk Management with Automated, Configurable Parameters
-
Independent Scientists Published a Review Article Demonstrating That Can-Fite Drugs Have Therapeutic Effects on Heart Diseases
-
ConocoPhillips to acquire Marathon Oil Corporation in all-stock transaction; provides shareholder distribution update
-
PANERA IS IN ITS MORE IS MORE ERA WITH THE MOST VALUABLE UNLIMITED SIP CLUB OFFER TO-DATE JUST IN TIME FOR SUMMER
-
Vetsource launches third pet pharmacy to support customer growth
-
bluebird bio Appoints O. James Sterling as Chief Financial Officer
-
Davies’ Evaluation Endorses DataVisor’s Enhanced AML/BSA Solutions, Affirming Operational Integrity and Seamless Investigation Processes for FIs
-
TrueBlue's PeopleReady Skilled Trades Honors Careers in the Trades Amidst Skilled Labor Shortage
-
ReposiTrak Adds 25 New Produce Companies to the Queue for the Rapidly Expanding Food Traceability Network
-
The City of Orlando Partners With AI Startup PETE To Scale Workforce Learning Of Kia Center and Camping World Stadium
-
Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST™
-
Medable and Masimo Partner to Bring Best-in-Class Wearable Devices to Clinical Research, Capturing Rich Subjective and Objective Data
-
Origin Materials and Bachmann Group to Mass Produce PET Caps and Closures
-
Aldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference
-
CHRIS HEMSWORTH, CHRISTINA RICCI, KEN JEONG, WILL ARNETT AND AULI'I CRAVALHO SQUAD UP WITH SUPERCELL FOR GLOBAL GAME LAUNCH
-
Kymera Therapeutics to Participate in Upcoming June Investor Conferences
-
Trinity Lutheran School Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students
-
Plum Teams Up with hireEZ to Improve Recruiting Outcomes Through Job Matching
-
AGI Responds to Media Report of Unsolicited Proposal
-
Alentis Receives FDA Orphan Drug Designation for Lixudebart to Treat Idiopathic Pulmonary Fibrosis
-
Ryan Named to Newsweek’s America’s Greatest Workplaces 2024 for Mental Wellbeing
-
Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference
-
Grey Wolf Therapeutics to Present First Clinical Data for GRWD5769, a First-in-Class ERAP1 Inhibitor, at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting
-
Assertio Announces the Appointment of Brendan P. O’Grady as New CEO
-
Aethon Energy to Acquire Tellurian Integrated Upstream Assets
-
Climate Tech VC Clean Energy Ventures Closes $305M Fund II Aiming to Mitigate 75 Gigatons of Emissions by 2050
-
Find Therapeutics to Participate in Upcoming Conferences
-
Covalon Announces Profitable Second Quarter Fiscal 2024 Results
-
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator
-
Circle Launches in Brazil to Catalyze Digital Dollar Access
-
ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing
-
Element 1 Corp. and Ballard Power Systems Collaborate on Revolutionary Hydrogen Power Solutions
-
Meketa Capital Launches Website
-
D-Wave Quantum Featured in The Wall Street Journal
-
Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference
-
Plymouth Industrial REIT to Present at Nareit’s REITweek 2024
-
Lotus Technology Reports Unaudited First Quarter 2024 Financial Results
-
Bitfarms Responds to Unsolicited Proposal from Riot Platforms
-
Electric Vehicle Brands Must Improve Mobile App Connectivity to Meet Owners’ Needs, J.D. Power Finds
-
Kynexis Appoints Esteemed Scientific Advisory Board Members to Advance Precision Therapeutics for Brain Diseases
-
Cielo Announces Appointment of New Auditor
-
73% of Businesses Struggle with Payment Delays, According to Rapyd’s 2024 State of Payments for High-Opportunity Industries
-
Athira Pharma to Participate in Upcoming June Conferences
-
Dragonfly Energy to Participate in June 2024 Conferences
-
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024
-
Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024
-
Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabetes Association’s 84th Scientific Sessions
-
Looba.ai Joins athenahealth’s Marketplace Program to Provide Ambient Medical Documentation & Translation
-
TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies
-
Scorpius Holdings Achieves 359% Year-Over-Year Increase in Revenue for the First Quarter of 2024


